Presentation is loading. Please wait.

Presentation is loading. Please wait.

P75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression.

Similar presentations


Presentation on theme: "P75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression."— Presentation transcript:

1 p75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression levels are higher in patients with JIA with the highest number of inflamed joints (**p<0.01). (B) p75NTR mRNA levels found in SFMC of patients with JIA (n=57) correlate with the number of active joints (rs=0.43; p=0.001) and (C) with C reactive protein levels (n=50; rs=0.39; p=0.006). JIA, juvenile idiopathic arthritis; SFMC, mononuclear cells isolated from synovial fluids. p75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression levels are higher in patients with JIA with the highest number of inflamed joints (**p<0.01). (B) p75NTR mRNA levels found in SFMC of patients with JIA (n=57) correlate with the number of active joints (rs=0.43; p=0.001) and (C) with C reactive protein levels (n=50; rs=0.39; p=0.006). JIA, juvenile idiopathic arthritis; SFMC, mononuclear cells isolated from synovial fluids. Gaetana Minnone et al. RMD Open 2017;3:e000441 Copyright © BMJ Publishing Group & EULAR. All rights reserved.


Download ppt "P75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression."

Similar presentations


Ads by Google